Trump’s Canada drug import plan can’t happen without big pharma

Bloomberg

13 August 2019 - Distributors see no incentive to export for fear of reprisals.

U.S. President Donald Trump’s plan to import cheap Canadian drugs overlooks a crucial fact: it can’t happen without the cooperation of major drugmakers, the very industry he’s trying to undercut.

Even as alarm grows in Canada over the prospect of Americans draining their supply of medicines, there’s little reason to believe the U.S. proposal would worsen the country’s drug shortages. But the fear plays into the hands of the powerful drug companies seeking to protect their U.S. profit margins.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing